Galderma Group AG (XSWX:GALD) Total Liabilities: CHF4,179 Mil (As of Dec. 2025)


XSWX:GALD Galderma Group AG XSWX:GALD
15 GF Score
Price CHF178.25
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Total Liabilities?

Galderma Group AG XSWX:GALD -0.14% 15 Total Liabilities is CHF4,179 Mil as of Dec. 2025. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Galderma Group AG's Total Liabilities for the quarter that ended in Dec. 2025 was CHF4,179 Mil.

Galderma Group AG's quarterly Total Liabilities declined from Dec. 2024 (CHF4,303.75 Mil) to Jun. 2025 (CHF4,185.54 Mil) and declined from Jun. 2025 (CHF4,185.54 Mil) to Dec. 2025 (CHF4,178.94 Mil).

Galderma Group AG's annual Total Liabilities declined from Dec. 2023 (CHF6,141.81 Mil) to Dec. 2024 (CHF4,303.75 Mil) and declined from Dec. 2024 (CHF4,303.75 Mil) to Dec. 2025 (CHF4,178.94 Mil).

Galderma Group AG Total Liabilities Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Total Liabilities Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
0.00 0.00 6,141.81 4,303.75 4,178.94

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial 6,141.81 4,421.63 4,303.75 4,185.54 4,178.94
XSWX:GALD
15GF Score
Galderma Group AG XSWX:GALD
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Galderma Group AG's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1637.63+(2142.864+315.572
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+82.878+0)
=4,179

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=10672.882-6493.938
=4,179

Galderma Group AG's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1637.63+(2142.864+315.572
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+82.878+0)
=4,179

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=10672.882-6493.938
=4,179

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of CHF4,179 Mil mean?
Galderma Group AG (XSWX:GALD) has a Total Liabilities of CHF4,179 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Galderma Group AG and its competitors.
Is Galderma Group AG's Total Liabilities too high?
Galderma Group AG's current Total Liabilities is CHF4,179 Mil. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Total Liabilities compare to ZTS and UTHR?
Galderma Group AG's Total Liabilities of CHF4,179 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Galderma Group AG and its competitors. Galderma Group AG's current Total Liabilities is CHF4,179 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Total Liabilities of CHF4,179 Mil. The current Total Liabilities is CHF4,179 Mil. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Total Liabilities is CHF4,179 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score

Get the complete analysis for XSWX:GALD

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF178.25
Price